Among patients eligible for metabolic and bariatric surgery (MBS), glucagon-like peptide-1 receptor agonist (GLP-1 RA) ...

In patients with diabetes and multivessel CAD, ticagrelor fails to meet noninferiority criteria compared with prasugrel at 1-year post-PCI.

Topline data were announced from a phase 3 trial evaluating DTX301 (avalotcagene ontaparvovec) for the treatment of OTC deficiency.

The new guidance includes recommendations for MRI and transvaginal ultrasonography in the evaluation of suspected endometriosis.

A predictive nomogram incorporating 16 clinical and biochemical variables demonstrated high diagnostic performance, with a sensitivity of 0.88 and a specificity of 0.92 for identifying uterine ...

Deaths linked to pregnancy and childbirth fell slightly in the United States in 2024, according to a new study.

Test your knowledge on the top endocrinology research findings from February 2026. In February, the research realm yielded an abundance of clinical findings that can shift your endocrine practice. The ...

Desmoda (desmopressin acetate) Vasopressin 2 receptor agonist Management of central diabetes insipidus as antidiuretic replacement therapy for adults and pediatric patients. FDA Approves Desmoda Oral ...

Current smoking in GD is linked to higher TRAb levels, increased odds of orbitopathy, and higher 12-month relapse risk after drug withdrawal.

Treatment with GLP-1 RAs for T2D and obesity is independently associated with an increased risk for osteoporosis, gout, and osteomalacia.

Patients with MDD exhibit significantly higher triglyceride levels, which correlate with worse functional impairment scores.